Gynecological | CancerDigest

Gynecological Cancers

Niraparib nearly doubles progression-free survival in prostate cancer with specific genetic mutations

Men with prostate cancer whose tumors have specific genetic mutations saw a nearly 50 percent reduction in the risk of cancer progression when they received naraparib.

Michael O'Leary

Risk of anal cancer twice as high for cervical cancer survivors

Anoscopy is the direct visualization of the anus using a speculum. It is used to screen, diagnose, and evaluate perianal and anal...

Michael O'Leary

Study shows two high-dose radiation sessions as effective as standard multi-session treatments for endometrial cancer

High-dose radiation uses of radiation tubes that produce radiation at a fast rate so that the treatment can be completed in minutes....

Michael O'Leary

New drug improves survival in advanced ovarian cancer

CANCER DIGEST – June 24, 2023 – Nearly half of women with advanced ovarian cancer that is resistant to standard chemotherapy survived...

Michael O'Leary

Keytruda boosts survival in advanced cervical cancer as first line therapy

CANCER DIGEST – May 27, 2023 – Women with persistent, recurrent or cervical cancer that has spread to other tissues had improved overall...

Michael O'Leary

New combination therapy shows promise for advanced ovarian cancer

Saturday, February 19, 2022 CANCER DIGEST – Feb. 19, 2022 – Ovarian cancer patients whose tumors have recurred or resisted standard...

Michael O'Leary

Ultra-processed foods increasingly linked to high cancer risk

CANCER DIGEST – Feb. 7, 2023 – A dietary study of 200,000 people between the ages of 40 and 69 over a three year period shows a link...

Michael O'Leary